Skip to main content
OpenTrials
Completed

NCT Number: NCT05925153

Vision Screening Study for College Students at Nankai University

The prevalence of myopia among high school students in China is as high as 80%-90%. For college students with longer years of education, the majority of myopia and the factors influencing the prevalence of high myopia should be better understood for timely prevention and treatment. This study aims to investigate the prevalence of myopia and education-related influencing factors among college students at Nankai University.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myoma Neoplasms Neoplasms by Histologic Type Neoplasms, Connective and Soft Tissue Neoplasms, Muscle Tissue

Age range

16 year–30 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Tiajin Eye Hospital

Tianjin, Tianjin Municipality, 300020, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All 1st year students

Exclusion criteria

  • No eye diseases such as cataracts, glaucoma,keratoconus, etc.
  • No psychiatric disorders
  • Astigmatism ≤ -6.00D

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Prevalence of myopia

    Time frame: One day measurement

    Myopia was defined as an equivalent spherical refraction ≤ -0.50D in either eye

  2. Prevalence of high myopia

    Time frame: One day measurement

    High myopia was defined as an equivalent spherical refraction ≤ -6.00D in either eye

Secondary outcomes

  1. Blood pressure

    Time frame: One day measurement

    Venous blood pressure was measured using a sphygmomanometer, and systolic and diastolic blood pressure results were recorded.

  2. Pulse

    Time frame: One day measurement

    Measure the number of pulses in the quiet state and record the number of beats per minute.

Sponsors and collaborators

Lead sponsor

Tianjin Eye Hospital

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 29, 2023
Registry last updated
Jun 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.